Ischemic Brain Injury Ameliorated ByActivation Of Cortical Type 2 Cannabinoid Receptors

A new study published in the March issue of The American Journal of Pathology suggests that cortical type 2 cannabinoid (CB2) receptors might serve as potential therapeutic targets for cerebral ischemia. Researchers found that the cannabinoid trans-caryophyllene (TC) protected brain cells from the effects of ischemia in both in vivo and in vitro animal models. In rats, post-ischemic treatment with TC decreased cerebral infarct size and edema...
Source: Health News from Medical News Today - Category: Consumer Health News Tags: Stroke Source Type: news